GB1426039A - Haptoglobin in aqueous solution and process for tits preparation - Google Patents
Haptoglobin in aqueous solution and process for tits preparationInfo
- Publication number
- GB1426039A GB1426039A GB804874A GB804874A GB1426039A GB 1426039 A GB1426039 A GB 1426039A GB 804874 A GB804874 A GB 804874A GB 804874 A GB804874 A GB 804874A GB 1426039 A GB1426039 A GB 1426039A
- Authority
- GB
- United Kingdom
- Prior art keywords
- haptoglobin
- tits
- preparation
- aqueous solution
- ammonium sulphate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Abstract
To prepare purified human serum haptoglobin, aqueous solutions of alpha - and beta -globulin fractions from human blood plasma are subjected to ammonium sulphate fractionation. The precipitates which separate out at ammonium sulphate concentrations of 30 to 40 % are collected and dissolved in water and contacted with an anion exchanger, whereupon the haptoglobin is chemically bound thereto. To obtain the pure haptoglobin, it is eluted from the ion exchanger. The haptoglobin is suitable for preventing or treating haemolytic kidney disorders.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12860673A JPS5322139B2 (en) | 1973-11-15 | 1973-11-15 | |
JP12860573A JPS5337406B2 (en) | 1973-11-15 | 1973-11-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1426039A true GB1426039A (en) | 1976-02-25 |
Family
ID=26464211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB804874A Expired GB1426039A (en) | 1973-11-15 | 1974-02-21 | Haptoglobin in aqueous solution and process for tits preparation |
Country Status (5)
Country | Link |
---|---|
CH (1) | CH608190A5 (en) |
DE (1) | DE2409650C3 (en) |
ES (1) | ES423697A1 (en) |
FR (1) | FR2251314B1 (en) |
GB (1) | GB1426039A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014055552A1 (en) * | 2012-10-03 | 2014-04-10 | Csl Behring Llc | A method of purifying proteins |
US9145448B2 (en) | 2004-10-19 | 2015-09-29 | Bio Products Laboratory Limited | Method for the isolation of haptoglobin |
AU2013203930B2 (en) * | 2012-10-03 | 2016-01-28 | Csl Behring Ag | A method of purifying proteins |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52128205A (en) * | 1976-04-16 | 1977-10-27 | Green Cross Corp:The | Prophylactic and therapeutic drugs for cerebro-vascular contraction |
-
1974
- 1974-02-21 GB GB804874A patent/GB1426039A/en not_active Expired
- 1974-02-26 CH CH268074A patent/CH608190A5/en not_active IP Right Cessation
- 1974-02-27 ES ES423697A patent/ES423697A1/en not_active Expired
- 1974-02-28 FR FR7406943A patent/FR2251314B1/fr not_active Expired
- 1974-02-28 DE DE19742409650 patent/DE2409650C3/en not_active Expired
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9145448B2 (en) | 2004-10-19 | 2015-09-29 | Bio Products Laboratory Limited | Method for the isolation of haptoglobin |
WO2014055552A1 (en) * | 2012-10-03 | 2014-04-10 | Csl Behring Llc | A method of purifying proteins |
CN104968676A (en) * | 2012-10-03 | 2015-10-07 | 美国杰特贝林生物制品有限公司 | A method of purifying proteins |
AU2013203930B2 (en) * | 2012-10-03 | 2016-01-28 | Csl Behring Ag | A method of purifying proteins |
US9534029B2 (en) | 2012-10-03 | 2017-01-03 | Csl Behring Ag | Method of purifying proteins |
US9937229B2 (en) | 2012-10-03 | 2018-04-10 | Csl Behring Ag | Methods of treatment using hemopexin compositions |
US10918696B2 (en) | 2012-10-03 | 2021-02-16 | Csl Behring Ag | Methods of treatment using hemopexin compositions |
Also Published As
Publication number | Publication date |
---|---|
FR2251314B1 (en) | 1978-07-07 |
DE2409650B2 (en) | 1979-03-22 |
ES423697A1 (en) | 1976-04-16 |
DE2409650A1 (en) | 1975-05-28 |
CH608190A5 (en) | 1978-12-29 |
DE2409650C3 (en) | 1979-11-08 |
FR2251314A1 (en) | 1975-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59505786D1 (en) | METHOD FOR THE DEPARATION OR REMOVAL OF ENDOTOXINS | |
DE3587941T2 (en) | DEVICE FOR PROVISIONAL REPERFUSION TREATMENT OF HEART ATTACK SYMPTOMS. | |
DK0447585T3 (en) | Process for the preparation of an intravenously tolerant immunoglobulin G preparation | |
GB1487169A (en) | Production of egg white substitute from whey | |
FR2548670B1 (en) | PROCESS FOR THE PREPARATION OF THE MAIN BLOOD HEMOLYSIS PROTEINS IN UNDENATURED FORM | |
GB1496726A (en) | Fractionation of proteins by electrical means | |
AT379310B (en) | METHOD FOR PRODUCING AN ANTITHROMBIN III-HEPARIN OR ANTITHROMBIN III HEPARINOID CONCENTRATE | |
JPS5944286B2 (en) | Purification method of bovine thrombin | |
GB1426039A (en) | Haptoglobin in aqueous solution and process for tits preparation | |
Grimbleby et al. | Binding of trichloroacetic acid by protein | |
ES437046A2 (en) | Manufacture of novel amino acid derivative | |
GB1369488A (en) | Method of removing organic materials bacteria or viruses from aqueous solutions thereof | |
ES465180A1 (en) | Immunoglobulin having a reduced complement fixation, a process for its preparation and agents containing this immunoglobulin | |
Seegers et al. | Comparative properties of purified human and bovine prothrombin | |
GB1018528A (en) | New physiologically active protein fractions from mistletoe and process for their preparation | |
SE8305252D0 (en) | PROCEDED THE PURIFICATION OF SOLUTIONS AQUEUSES URANIFERES CONTENANT DU ZIRCONIUM ET / OU HAVNIUM ENTRE AUTRES IMPURETES | |
Nagashima et al. | Coagulating effect on calcium carbonate of sulfated glycoproteins isolated from pathological human bile | |
ES524890A0 (en) | PRODUCTION METHOD OF COMPOSITIONS CONTAINING GLOBULIN GAMMA | |
JPS55111768A (en) | Decolorization and purification of stevia sweet component | |
JPS5632421A (en) | Fractionation of plasma protein | |
PL85201B1 (en) | ||
GB1029099A (en) | Process for the production of pure glucose oxidase | |
GB906860A (en) | Improvements relating to blood coagulation test reagents | |
JPS5330482A (en) | Water making method | |
ATE8986T1 (en) | PROCESS FOR PRODUCTION OF FORMALDEHYDE. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PE20 | Patent expired after termination of 20 years |
Effective date: 19940220 |